^
1d
Glucocorticoid receptor activated by dexamethasone promotes the chemoresistance and stemness of lung cancer. (PubMed, Drug Resist Updat)
These results revealed dexamethasone could promote chemoresistance and stemness in lung cancer by inducing nuclear-translocation of GR/β-catenin complex. In the long run, more cautions are needed when glucocorticoids are prescribed to patients during chemotherapy.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1)
|
paclitaxel • dexamethasone
2d
Enrollment closed • Enrollment change
|
CD4 (CD4 Molecule)
|
Xpovio (selinexor) • dexamethasone • pomalidomide • Empliciti (elotuzumab)
2d
Case Report: Secondary myelodysplastic syndrome following autologous stem cell transplantation in a patient with POEMS syndrome. (PubMed, Front Immunol)
After induction therapy with the lenalidomide-dexamethasone (RD) regimen, ASCT is performed and partial remission is achieved. The pathogenesis of secondary MDS in POEMS syndrome is discussed from three aspects: cytotoxic therapy, genetic predisposition, and SARS-CoV-2 infection. This case underscores the importance of prolonged surveillance for secondary myeloid neoplasms (sMN) in POEMS patients and suggests that early genomic profiling and individualized treatment may improve outcomes.
Journal
|
TP53 (Tumor protein P53)
|
TP53 mutation
|
lenalidomide • dexamethasone
3d
Enrollment closed
|
lenalidomide • bortezomib • prednisone • dexamethasone • melphalan • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
3d
In vitro dexamethasone suppression of cytokine production assay and plasma total and free cortisol responses to ACTH in healthy volunteers. (PubMed, Sci Rep)
In this exploratory study, ACTH [1-24]-stimulated cortisol responses did not correlate with glucocorticoid sensitivity measured by the DSCP assay. Findings should be interpreted as preliminary and hypothesis-generating given current assay limitations.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha)
|
dexamethasone
5d
Lipopolysaccharide Sensitizes Steroid-Induced Brain Injury in Neonatal Rat Pups. (PubMed, Mediators Inflamm)
Rat pups received lipopolysaccharide (LPS) on postnatal Day 1 (P1), followed by tapering doses of dexamethasone (Dex) or hydrocortisone (HC) from P2 to P4. GR mRNA was significantly reduced in cortex, striatum, hippocampus, and cerebellum in LPS-HC group, with MR mRNA reduction limited primarily to the striatum. LPS sensitized the immature brain to Dex or HC-related cell death to possible apoptosis and augmented the LPS-induced disruption of synaptic integrity in certain brain regions, potentially via altered GR and MR expression that may modulate corticosteroid receptor signaling.
Preclinical • Journal
|
NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1) • DLG4 (Discs Large MAGUK Scaffold Protein 4)
|
dexamethasone
8d
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients (clinicaltrials.gov)
P4, N=120, Not yet recruiting, Tianjin Medical University Cancer Institute and Hospital
New P4 trial
|
Enhertu (fam-trastuzumab deruxtecan-nxki) • dexamethasone • megestrol
9d
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia. (PubMed, Cephalalgia)
We also evaluated the effect of betamethasone on CGRP mRNA stability and release from the mouse TG, as well as on mouse spontaneous or nitroglycerin-induced cephalic allodynia.ResultsWe report that dexamethasone triggered transcriptional activation of the rat and human CGRP gene, also increasing transcript levels of RAMP1 but not of CLR in cultured cells. Of note, although a 13-fold increase of the CGRP releasable pool occurred in the TG of betamethasone-treated mice, the animals were not sensitized to cephalic allodynia.ConclusionsIn keeping with the emerging immunosuppressing effects of CGRP, corticosteroids increase its expression in rat and human cell lines, as well as in rodent TG. Evidence that a substantial increase of releasable CGRP in the TG does not reduce orofacial pain thresholds suggests that basal release of endogenous CGRP differs from its exogenous administration in terms of trigeminal afferent sensitization.
Preclinical • Journal
|
CALCRL (Calcitonin Receptor Like Receptor)
|
dexamethasone • nitroglycerin
10d
ContactLens: Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema (clinicaltrials.gov)
P1/2, N=6, Recruiting, Massachusetts Eye and Ear Infirmary | Trial completion date: Dec 2024 --> Dec 2027 | Trial primary completion date: Dec 2023 --> Dec 2027
Trial completion date • Trial primary completion date
|
dexamethasone
10d
Trial completion
|
lenalidomide • Darzalex (daratumumab) • carfilzomib • dexamethasone
11d
Enrollment closed
|
lenalidomide • bortezomib • carfilzomib • dexamethasone • pomalidomide • Tecvayli (teclistamab-cqyv)
12d
Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery (clinicaltrials.gov)
P4, N=60, Completed, Poznan University of Medical Sciences | Trial completion date: Jan 2026 --> Oct 2025 | Not yet recruiting --> Completed
Trial completion • Trial completion date
|
dexamethasone